Your session is about to expire
← Back to Search
Intervention Group 1 - Test Results Given for Pancreatic Cancer
N/A
Waitlist Available
Research Sponsored by Qure Healthcare, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up [4 months]
Awards & highlights
Study Summary
This trial looks at how doctors treat common conditions, to see which treatments work best.
Eligible Conditions
- Pancreatic Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ [4 months]
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~[4 months]
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
CPV-measured change in treatment Quality
CPV-measured differences in cost of care between control and intervention arms
CPV-measured rate of adoption for the diagnostic test
+3 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Group 2 - Test Results OptionalExperimental Treatment1 Intervention
Intervention Group 2 will receive information regarding the test and will be given the test results if selected in Round 2 of CPV administration.
Group II: Intervention Group 1 - Test Results GivenExperimental Treatment1 Intervention
Intervention Group 1 will receive information regarding the test and will be given the test results, whether selected or not, in Round 2 of CPV administration.
Group III: Standard PracticeActive Control1 Intervention
The control group treats their simulated patients using standard practice and has no introduction to the new diagnostic test.
Find a Location
Who is running the clinical trial?
Qure Healthcare, LLCLead Sponsor
21 Previous Clinical Trials
3,955 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You regularly check patients who may be at risk of developing pancreatic cancer during your medical practice.You need to have internet access.You've already taken part in this test before.
Research Study Groups:
This trial has the following groups:- Group 1: Standard Practice
- Group 2: Intervention Group 1 - Test Results Given
- Group 3: Intervention Group 2 - Test Results Optional
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are participants still being accepted for this clinical experiment?
"Clinicaltrials.gov displays that the trial published on February 1st 2023 is no longer actively seeking patients, yet there are 698 other clinical trials currently enrolling individuals."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger